4,635
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of abatacept for patients with Sjögren’s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren’s syndrome Endocrinopathy) trial

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 891-899 | Received 05 Jan 2016, Accepted 16 Feb 2016, Published online: 26 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Y Endo, T Koga, S-y Kawashiri, S Morimoto, A Nishino, M Okamoto, S Tsuji, A Takatani, T Shimizu, R Sumiyoshi, T Igawa, N Iwamoto, K Ichinose, M Tamai, H Nakamura, T Origuchi, Y Ueki, T Yoshitama, N Eiraku, N Matsuoka, A Okada, K Fujikawa, H Hamada, T Tsuru, S Nagano, Y Arinobu, T Hidaka, Y Tada & A Kawakami. (2021) Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study. Scandinavian Journal of Rheumatology 50:1, pages 15-19.
Read now
Toshio Odani & John A. Chiorini. (2019) Targeting primary Sjögren’s syndrome. Modern Rheumatology 29:1, pages 70-86.
Read now
Hiroyuki Takahashi, Hiroto Tsuboi, Masahiro Yokosawa, Hiromitsu Asashima, Tomoya Hirota, Yuya Kondo, Isao Matsumoto & Takayuki Sumida. (2018) Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment. Modern Rheumatology 28:2, pages 300-307.
Read now

Articles from other publishers (32)

Ali Akgul, Christian Furlan Freguia, Massimo Maddaloni, Carol Hoffman, Alexandria Voigt, Cuong Q. Nguyen, Neil A. Fanger, Gary R. Fanger & David W. Pascual. (2023) Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease. Scientific Reports 13:1.
Crossref
I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri & F. Ciccia. (2023) The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis. Reumatismo 74:4.
Crossref
Hiroto Tsuboi, Hirofumi Toko, Fumika Honda, Saori Abe, Hiroyuki Takahashi, Mizuki Yagishita, Shinya Hagiwara, Ayako Ohyama, Yuya Kondo, Kazuhisa Nakano, Yoshiya Tanaka, Toshimasa Shimizu, Hideki Nakamura, Atsushi Kawakami, Yuichiro Fujieda, Tatsuya Atsumi, Yasunori Suzuki, Mitsuhiro Kawano, Naoshi Nishina, Yuko Kaneko, Tsutomu Takeuchi, Hitomi Kobayashi, Masami Takei, Michihiro Ogasawara, Naoto Tamura, Yoshinari Takasaki, Kazuhiro Yokota, Yuji Akiyama, Toshihide Mimura, Kosaku Murakami, Tsuneyo Mimori, Shiro Ohshima, Naoto Azuma, Hajime Sano, Susumu Nishiyama, Isao Matsumoto & Takayuki Sumida. (2023) Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials. Modern Rheumatology 33:1, pages 160-168.
Crossref
Moiz Ehtesham, Anupama Tiwari, Rose Sneha George & Ruben A. Peredo. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
Anna Radziszewska, Zachary Moulder, Elizabeth C. Jury & Coziana Ciurtin. (2022) CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease. International Journal of Molecular Sciences 23:19, pages 11431.
Crossref
Kunihiro Otsuka, Mami Sato, Takaaki Tsunematsu & Naozumi Ishimaru. (2022) Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome. Viruses 14:7, pages 1474.
Crossref
Shinjiro Kaieda, Kyoko Fujimoto, Keita Todoroki, Yushi Abe, Jingo Kusukawa, Tomoaki Hoshino & Hiroaki Ida. (2022) Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis. Modern Rheumatology 32:4, pages 761-769.
Crossref
Pantea Mohammadi, Mahvash Hesari, Maryam Chalabi, Farhad Salari & Fatemeh Khademi. (2022) An overview of immune checkpoint therapy in autoimmune diseases. International Immunopharmacology 107, pages 108647.
Crossref
Janaina Barbieri dos Santos HELMS, Carlos Augusto BARBOSA, Aline Corrêa ABRAHÃO, Marcia Grillo CABRAL, Blanca Elena Rios Gomes BICA & Sandra Regina TORRES. (2022) Are salivary flow rates associated with histopathologic aspects in patients with rheumatoid arthritis?. Brazilian Oral Research 36.
Crossref
Min Liu, Yikai Yu & Shaoxian Hu. (2021) A review on applications of abatacept in systemic rheumatic diseases. International Immunopharmacology 96, pages 107612.
Crossref
Robert I. Fox, Carla M. Fox, Jacques Eric Gottenberg & Thomas Dörner. (2021) Treatment of Sjögren’s syndrome: current therapy and future directions. Rheumatology 60:5, pages 2066-2074.
Crossref
Meletios Rozis, John Vlamis, Elias Vasiliadis, Clio Mavragani, Spiros Pneumaticos & Dimitrios Stergios Evangelopoulos. (2021) Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View. Journal of Clinical Medicine 10:8, pages 1574.
Crossref
Alan N Baer, Jacques-Eric Gottenberg, E William St Clair, Takayuki Sumida, Tsutomu Takeuchi, Raphaèle Seror, Gary Foulks, Marleen Nys, Sumanta Mukherjee, Robert Wong, Neelanjana Ray & Hendrika Bootsma. (2021) Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial. Annals of the Rheumatic Diseases 80:3, pages 339-348.
Crossref
Austin Anderson, Erin Hudson, Lijun Yang, Winnie W. Hui, Shuhong Han, Haoyang Zhuang, Robert Thoburn & Westley H. Reeves. 2021. Sjögren's Syndrome and Oral Health. Sjögren's Syndrome and Oral Health 117 136 .
Amrita Srivastava & Helen P. Makarenkova. (2020) Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome. International Journal of Molecular Sciences 21:23, pages 9172.
Crossref
Huijuan Zhang, Haoze Zhang, Dai Gao, Wenhui Xie, Yan Geng & Zhuoli Zhang. (2020) Overlapping Sjogren’s syndrome reduces the probability of reaching target in rheumatoid arthritis patients: a propensity score matched real-world cohort from 2009 to 2019. Arthritis Research & Therapy 22:1.
Crossref
William de Jesús Ríos-Ríos, Sorely Adelina Sosa-Luis & Honorio Torres-Aguilar. (2020) T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome. Biomolecules 10:11, pages 1539.
Crossref
Juan C. Sarmiento-Monroy & José A. Gómez-Puerta. (2020) Poliautoinmunidad en síndrome de Sjögren. Revista Colombiana de Reumatología 27, pages 58-66.
Crossref
Clio P. Mavragani & Haralampos M. Moutsopoulos. (2020) Sjögren's syndrome: Old and new therapeutic targets. Journal of Autoimmunity 110, pages 102364.
Crossref
Valquiria G. Dinis, Vilma T. Viana, Elaine P. Leon, Clóvis A. Silva, Carla G. Saad, Julio C. Moraes, Eloisa S. Bonfa & Ana C. Medeiros-Ribeiro. (2020) Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control. Clinical Rheumatology 39:6, pages 1747-1755.
Crossref
Lucas L. van den Hoogen & Jacob M. van Laar. (2020) Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndrome. Best Practice & Research Clinical Rheumatology 34:1, pages 101485.
Crossref
Adriana Cristiane Machado, Laura Caldas dos Santos, Tania Fidelix, Ilda Lekwitch, Simone Barbosa Soares, André Felipe Gasparini, Juliana Venturini Augusto, Nelson Carvas Junior & Virginia Fernandes Moça Trevisani. (2019) Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren’s syndrome. Clinical Rheumatology 39:1, pages 243-248.
Crossref
Charalampos Skarlis, Nikolaos Marketos & Clio P. Mavragani. (2019) Biologics in Sjögren's syndrome. Pharmacological Research 147, pages 104389.
Crossref
Luiz A. Gueiros, Katherine France, Rachael Posey, Jacqueline W. Mays, Barbara Carey, Thomas P. Sollecito, Jane Setterfield, Sook Bin Woo, Donna Culton, Aimee S. Payne, Giovanni Lodi, Martin S. Greenberg & Scott De Rossi. (2019) World Workshop on Oral Medicine VII : Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review . Oral Diseases 25:S1, pages 102-110.
Crossref
Hideki Nakamura, Yoshiro Horai, Toshimasa Shimizu & Atsushi Kawakami. (2018) Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren’s Syndrome. International Journal of Molecular Sciences 19:8, pages 2369.
Crossref
Grace Thompson, Andrew Mclean-Tooke, Jeremy Wrobel, Melanie Lavender & Michaela Lucas. (2018) Sjögren Syndrome With Associated Lymphocytic Interstitial Pneumonia Successfully Treated With Tacrolimus and Abatacept as an Alternative to Rituximab. Chest 153:3, pages e41-e43.
Crossref
Chadwick R. Johr & Frederick B. Vivino. (2018) Biologic Therapy in the Treatment of Sjögren’s Syndrome: a Clinical Perspective. Current Treatment Options in Rheumatology 4:1, pages 85-98.
Crossref
John A. Gonzales & Thomas M. Lietman. (2018) Ocular Involvement in Sjögren’s Syndrome: Advances in Therapy. Current Treatment Options in Rheumatology 4:1, pages 99-109.
Crossref
Carlo Selmi & M. Eric Gershwin. (2017) Chronic Autoimmune Epithelitis in Sjögren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review. Rheumatology and Therapy 4:2, pages 263-279.
Crossref
Elena Generali, Antonio Costanzo, Carlo Mainetti & Carlo Selmi. (2017) Cutaneous and Mucosal Manifestations of Sjögren’s Syndrome. Clinical Reviews in Allergy & Immunology 53:3, pages 357-370.
Crossref
Naoto Azuma & Hajime Sano. (2017) 19. Sjögren's Syndrome: Pathophysiology, Diagnosis and Treatment19)シェーグレン症候群:病態・診断・治療. Nihon Naika Gakkai Zasshi 106:9, pages 2035-2042.
Crossref
. (2017) Abatacept. Reactions Weekly 1661:1, pages 15-15.
Crossref